These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10197604)

  • 1. Comparison of cytochrome P450- and peroxidase-dependent metabolic activation of the potent carcinogen dibenzo[a,l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites.
    Melendez-Colon VJ; Luch A; Seidel A; Baird WM
    Cancer Res; 1999 Apr; 59(7):1412-6. PubMed ID: 10197604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
    Melendez-Colon VJ; Luch A; Seidel A; Baird WM
    Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides.
    Melendez-Colon VJ; Smith CA; Seidel A; Luch A; Platt KL; Baird WM
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13542-7. PubMed ID: 9391062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
    King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
    Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
    Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
    Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantitation of dibenzo[a,l]pyrene--DNA adducts formed by rat liver microsomes in vitro: preponderance of depurinating adducts.
    Li KM; Todorovic R; Rogan EG; Cavalieri EL; Ariese F; Suh M; Jankowiak R; Small GJ
    Biochemistry; 1995 Jun; 34(25):8043-9. PubMed ID: 7794917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland.
    Todorovic R; Devanesan P; Rogan E; Cavalieri E
    Chem Res Toxicol; 2005 Jun; 18(6):984-90. PubMed ID: 15962933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures.
    Ralston SL; Lau HH; Seidel A; Luch A; Platt KL; Baird WM
    Cancer Res; 1994 Feb; 54(4):887-90. PubMed ID: 8313376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
    Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
    Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites.
    Melendez-Colon VJ; Luch A; Seidel A; Baird WM
    Carcinogenesis; 1999 Oct; 20(10):1885-91. PubMed ID: 10506100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
    Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
    Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
    Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,l]pyrene and Dibenzo[a,l]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro.
    Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1999 Sep; 12(9):796-801. PubMed ID: 10490500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies.
    Jankowiak R; Ariese F; Hewer A; Luch A; Zamzow D; Hughes NC; Phillips D; Seidel A; Platt KL; Oesch F; Small GJ
    Chem Res Toxicol; 1998 Jun; 11(6):674-85. PubMed ID: 9625736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis.
    Einolf HJ; Story WT; Marcus CB; Larsen MC; Jefcoate CR; Greenlee WF; Yagi H; Jerina DM; Amin S; Park SS; Gelboin HV; Baird WM
    Chem Res Toxicol; 1997 May; 10(5):609-17. PubMed ID: 9168260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.